The Defiance Daily Target 2X Long RKLB ETF (RKLX) provides leveraged 200% daily exposure to Rocket Lab (RKLB) shares, driven by the company's growth in medium-lift rockets, increasing launch frequency, and an upcoming acquisition of Iridium. This ETF is recommended for short-term traders due to its high volatility, compounding risk, and a beta of 2.80 relative to RKLB. While liquidity is strong, investors should consider trading costs from a 0.28% bid/ask spread and a 1.29% expense ratio. Overall, RKLX is positioned as a tool for tactical exposure rather than a long-term investment.
Rocket Lab Corporation reported its best quarter ever with record Q2 revenue, backlog reaching $2.4 billion, and strong gross margins. The company's defense segment is growing independently with $456 million in suborbital contracts, showing competiti...
Rocket Lab reported $234 million in revenue for Q2 and has a backlog of $2.36 billion, reflecting strong demand across its Electron, HASTE, Neutron, and Space Systems programs. The company is evolving from a launch service provider into a comprehensi...
AST SpaceMobile shares fell 4% following SpaceX's announcement of winding down Falcon 9 Starlink launches from Florida, shifting to Starship. This transition highlights risks for companies like AST SpaceMobile that rely on third-party launch provider...
Rocket Lab reported $234 million in revenue for Q2 and holds a $2.36 billion backlog, signaling strong demand. The company is advancing its Neutron rocket program with pricing above $50 million per launch, indicating customers see future launch capac...
Space launch stocks like SpaceX, Rocket Lab, and AST SpaceMobile dropped despite President Trump's memo directing federal agencies to aim for 1,000 launches annually by 2030, a significant increase from 178 last year. The market is cautious, focusing...
